| RCKT Stock | | | USD 14.10 0.01 0.07% |
Rocket Pharmaceuticals financial indicator trend analysis is much more than just breaking down Rocket Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rocket Pharmaceuticals is a good investment. Please check the relationship between Rocket Pharmaceuticals Non Current Assets Total and its Cash accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.
Non Current Assets Total vs Cash
Non Current Assets Total vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Rocket Pharmaceuticals Non Current Assets Total account and
Cash. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Rocket Pharmaceuticals' Non Current Assets Total and Cash is 0.43. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Cash in the same time period over historical financial statements of Rocket Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Rocket Pharmaceuticals' Non Current Assets Total and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Rocket Pharmaceuticals are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Non Current Assets Total i.e., Rocket Pharmaceuticals' Non Current Assets Total and Cash go up and down completely randomly.
Correlation Coefficient | 0.43 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Cash
Cash refers to the most liquid asset of Rocket Pharmaceuticals, which is listed under current asset account on Rocket Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Rocket Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Rocket Pharmaceuticals account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Rocket Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rocket Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.At this time, Rocket Pharmaceuticals'
Selling General Administrative is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 2.6
B in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 203.6
M in 2024.
Rocket Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Rocket Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rocket Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to
measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.